REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)
SEC filings, insider trading & institutional ownership from EDGAR.
Institutions
13
$1.71B held
Latest filings
10-K, 10-Q, 8-K, Form 4 & 13D/G. Sourced directly from SEC EDGAR
No filings are available yet.
Top holders
13F & 13D/G · latest quarter
| Holder | Filed | Value |
|---|---|---|
| MILLENNIUM MANAGEMENT LLC | May 15, 2026 | $579.34M |
| JPMORGAN CHASE & CO | May 13, 2026 | $556.20M |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | May 15, 2026 | $385.29M |
| Vanguard Capital Management | May 15, 2026 | $85.83M |
| GEODE CAPITAL MANAGEMENT, LLC | May 15, 2026 | $53.27M |
RVPH's filings are public. The insight is one click away.
Scrutar's AI reads every RVPH filing and surfaces what matters. Red flags, risk shifts, disclosure quality and key relationships. Cited to the source, free with an account.
Red Flag Detection20+ forensic checks per filingRisk RadarYear-over-year changes in risk factorsFiling DNADisclosure quality scored across six dimensionsSupply Chain GraphCustomers, suppliers & competitors mapped
Analyze RVPH filingsNo credit cardAI reports included on the free plan
Never miss a RVPH filing.
Get an email when RVPH files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Data as of Aug 30, 2026Source: SEC EDGAR.